🎤 Calling all AMP trainees with talent! Perform in the #AMP2026 talent show and receive a complimentary ticket to the Amazing Molecular Party on Nov. 13!
Email [email protected] by Oct. 30 with your proposed act (five minutes maximum).
Join us Oct. 29 at 1 p.m. Eastern for a free webinar exploring ctDNA-based MRD detection and its potential applications in risk stratification, surveillance and treatment selection.
educate.amp.org/local/catalo…
In leukemia testing, molecular labs face a difficult trade-off: broad detection of fusions and mutations or the deep sensitivity required for MRD. Watch this OCW to explore how @countablelabs' single-molecule counting assays are designed to address both.
player.vimeo.com/video/12310…
New AMP case report in CAP Today: "Comprehensive Molecular Characterization of an Aggressive Infant-Type Hemispheric Glioma with a Novel PRKAR2A::ALK Fusion" 👉 amp.org/AMP/assets/File/clin…
🗓️ Today’s the last day to register for #AMP2026 at the standard registration rate. Register by 11:59 p.m. Eastern to save.
Don’t wait until it’s too late!
Register: ow.ly/WwAW50ZVvY3
Today: Join us along with @ToniSepulvedaMD for a free webinar on alternative workflows for ordering biomarker and NGS tumor testing in colorectal and other gastrointestinal cancers covering multiple models and evaluate how these approaches affect outcomes.
educate.amp.org/local/catalo…
📅 Oct. 28 | 🕒 1 p.m. Eastern ➡️A practical path to NGS: Clonality and ultra-high sensitivity MRD assessment in lymphoid malignancies (hosted by Invivoscribe)
Register for free: us06web.zoom.us/webinar/regi…
🧛 Transform hematologic diagnostics with your molecular insights.
@JMDiagn invites papers on NGS panels, fusion detection, MRD and molecular testing in leukemias, lymphomas and related disorders.
Submit here: editorialmanager.com/jmdi/de…
Advocacy update: In a letter, 19 members of Congress have urged CMS not to make unilateral changes to surgical pathology service valuations in the 2027 Medicare Physician Fee Schedule.
Read the letter: amp.org/AMP/assets/File/advo…
➡️ Sunday: Last day to book your #AMP 2026 room with our discount.
Hotel information: ow.ly/qBox50ZYeuY
➡️ Tuesday: Last day for regular registration. After that, the (higher) on-site rate applies.
Register: ow.ly/Wk6h50ZYev0
FREE webinar ➡️A practical path to NGS: Clonality and ultra-high sensitivity MRD assessment in lymphoid malignancies
📅 Oct. 28 | 🕒 1 p.m. Eastern
us06web.zoom.us/webinar/regi…
How can circulating tumor DNA (ctDNA) help detect minimal residual disease (MRD) in solid tumors?
Join us Oct. 29 for a free webinar covering ctDNA-based MRD detection, emerging clinical applications and challenges in translating these tests into practice
educate.amp.org/local/catalo…
TODAY is the final broadcast in our Body of Knowledge series, based on the @JMDiagn papers. Join us at 1 p.m. ET to discuss:
✅Regulatory & standards organizations
✅U.S. lab regulations impacting clinical bioinformaticians
✅Data security best practices
register.gotowebinar.com/reg…
Engage with our advocacy experts and other professionals working to address critical challenges in the field of molecular pathology by joining us at #AMP2026 in Seattle, Nov. 10–14.
Be a part of the change you want to see. Register: ow.ly/BK6850ZVvTq














